// App-Quantinova.ai

TCT-45 : Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Researchers

Presenter

  • Andres Iniguez

Principal Investigators

  • Bernard Chevalier

  • Thomas Hovasse

  • Marie-Claude Morice

  • Alexander G. Osiev

  • Jawed Polad

  • Antonio Serra

Medical Centers

  • Jeroen Bosch Ziekenhuis, s-Hertogenbosch, Netherlands

  • ICPS, Massy, France

  • Complejo Hospital Universitario de Vigo, Vigo, Spain

  • Hospital de Sant Pau y Santa Creu, Barcelona, Spain

  • Institut Cardiovasculaire Paris Sud, Generale de Sante, Massy, France

Locations

  • France

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved